Constitutively Active Androgen Receptor Variants Upregulate Expression of Mesenchymal Markers in Prostate Cancer Cells

por Cottard, Félicie, Asmane, Irène, Erdmann, Eva, Bergerat, Jean-Pierre, Kurtz, Jean-Emmanuel, Céraline, Jocelyn
Publicado 2013

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer

por Cottard, Félicie, Madi-Berthélémy, Pauline Ould, Erdmann, Eva, Schaff-Wendling, Frédérique, Keime, Céline, Ye, Tao, Kurtz, Jean-Emmanuel, Céraline, Jocelyn
Publicado 2017

Fluorine NMR study of proline-rich sequences using fluoroprolines

por Sinnaeve, Davy, Ben Bouzayene, Abir, Ottoy, Emile, Hofman, Gert-Jan, Erdmann, Eva, Linclau, Bruno, Kuprov, Ilya, Martins, José C., Torbeev, Vladimir, Kieffer, Bruno
Publicado 2021

Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer

por Erdmann, Éva, Ould Madi Berthélémy, Pauline, Cottard, Félicie, Angel, Charlotte Zoe, Schreyer, Edwige, Ye, Tao, Morlet, Bastien, Negroni, Luc, Kieffer, Bruno, Céraline, Jocelyn
Publicado 2022

Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors

por Guyader, Charlotte, Céraline, Jocelyn, Gravier, Eléonore, Morin, Aurélie, Michel, Sandrine, Erdmann, Eva, de Pinieux, Gonzague, Cabon, Florence, Bergerat, Jean-Pierre, Poupon, Marie-France, Oudard, Stéphane
Publicado 2012